EU approves pharma deal with conditions
The European Commission has approved the takeover of Irish biopharma company Shire by Japanese drug maker Takeda, on the condition that Shire sells off a biologic still under development.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.